The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 PerkinElmer Inc.  (PKI) Trade Now »     Rate PKI  -  Discuss PKI  -  Add to Watch List         Graphic_subscribe

       Sector: Technology  >  Industry: Scientific & Technical Instr.
SocialPicks Sentiment:

** v.s. other stocks 		This Quarter's Sentiment:
All:
100.0%
Top:
100.0%
Rate PKI:


Home
Analysis & Videos
Quotes
Bull or Bear
Discuss
        

PKI: Bull or Bear? From:    SocialPicks  |  Blogsphere  |  All

SocialPicks Community



From the Blogosphere

Cord Blood Stocks: Cord Blood Transplants May Provide Cures for Babies While Still in the Womb
Tradinggoddess
 5 %
Duke University is studying the use of cord blood transplants in babies while still in the womb, in order to treat various metabolic disorders. The U.S. Food and Drug Administration has given approval for clinical trials.

Cord blood is blood that comes from umbilical cords, and contains a large amount of hematopoietic stem cells. Specialized cord blood banks are available to store this blood. Cord blood stem cells are considered far superior to stem cells from bone marrow. Many parents have their newborn's cord blood preserved in the event it may be needed at some point in the future for tr...
By  Trading Goddess   (-46.13%  risk: aggressive)  10/22/09 Comment


Analyst upgrades, downgrades and initiations: AMTD, JCG, JNJ, MOS, NOK ...

Filed under: Analyst reports, Analyst upgrades and downgrades, Nokia Corp. (NOK), Johnson and Johnson (JNJ), Analyst initiations

Analyst upgrades:

<>
  • Thomas Weisel upgraded PerkinElmer (NYSE: PKI) to Overweight from Market Weight on valuation as it sees limited downside to consensus estimates. The firm raised its target on shares to $20 from $18.
  • Jefferies upgraded WuXi PharmaTech (NYSE: WX) to Hold from Underperform following the Q2 results as it believes the company's cross-selling strategy is paying off. The firm raised its target on shares to $12 from $5.
    • <>FBR Capital upgraded <>J. ...
    By  Eric Buscemi   (+0.00%)  08/13/09 Comment


    Analyst upgrades, downgrades and initiations: DELL, IBM, IPCR, NETL ...

    Filed under: Analyst reports, Analyst upgrades and downgrades, Dell (DELL), International Business Machines (IBM), Analyst initiations

    Analyst upgrades:
    <>
  • Citigroup upgraded MEMC Electronic (NYSE: WFR) to Buy from Hold after channel checks indicated solar poly price pressures are easing. The firm added MEMC to its Top Picks Live list and raised its price target on shares to $24 from $15.
    • <>FBR Capital upgraded PHH Corp (NYSE: PHH) to Outperform from Market Perform to reflect an improvement in mortgage banking fundamentals and recent management changes at the company. The firm raised its t...
    By  Eric Buscemi   (+0.00%)  07/10/09 Comment


    Cord Blood Stocks
    Tradinggoddess
     5 %
    Cord blood has been in the news a lot recently. A Florida hospital is waiving the fee for the donation of cord blood. Five cord blood transfer centers in Spain have joined a study for the treatment of lymphoma and leukemia. And a cord blood bank in Texas has added Midland Memorial Hospital to is collection network.

    Cord blood is blood that comes from umbilical cords, and contains an extensive amount of hematopoietic stem cells. The blood is kept in depositories called blood banks. Cord blood stem cells are considered far superior to stem cells from bone marrow. Many parents have their newbo...
    By  Trading Goddess   (-46.13%  risk: aggressive)  06/06/09 Comment


    Analyst upgrades, downgrades and initiations: CNX, MA, CAT, MHS ...

    Filed under: Analyst reports, Analyst upgrades and downgrades, Caterpillar (CAT), Boston Scientific (BSX), MasterCard Inc'A' (MA), Analyst initiations

    Analyst upgrades:
    <>
  • Citigroup upgraded shares of Consol Energy (NYSE: CNX) to Buy from Hold following the company's lowered guidance as 2009 is fully contracted with a 26% price increase. The firm raised its target to $40 from $38.
  • Deutsche Bank upgraded AstraZeneca (NYSE: AZN) to Buy from Hold on valuation as it thinks the sell-off on the company's Q4 miss and cautious guidance is overdone.
    • <>Wachovia upgraded Boston Scientific (NYSE: ...
    By  Eric Buscemi   (+0.00%)  01/30/09 Comment



    ROCK-STAR INVESTORS
    Rank Name Sharpe Ratio Avg Return Followers
    1 noshoes 21.10 +34.25% 377
    2 Gerald Greene 18.14 +70.10% 208
    3 stockmarketfunding.com 17.66 +25.70% 55
    4 akiralegrand 13.47 +14.32% 61
    5 anup2104 12.13 +75.30% 38


    POPULAR STOCKS
    Symbol Company Name Sentiment
    C Citigroup Inc
    DRYS DryShips Inc.
    IBM International Business Machines Corp
    AMZN Amazoncom Inc
    CSCO Cisco Systems Inc
    RIO Companhia Vale Do Rio Doce

    TODAY'S HEADLINES

    TODAY'S TOP PICKS

    		 

    StreetInsider.com on PKI

    Visit streetinsider.com


    Discussion Wall + Add  
    turnerstocks   (+0.00%)
    How I Make $5,600 from $67 Weekly - Hidden Stock Tr.. - How I Make $5,600 from $67 Weekly - Hidden Stock Trading Trick - www.stocksolution.com
    +   0 replies

    turnerstocks   (+0.00%)
    How I Make $5,600 from $67 Weekly - Hidden Stock Tr.. - How I Make $5,600 from $67 Weekly - Hidden Stock Trading Trick - www.stocksolution.com http://www.stockcolution.com
    +   0 replies

    stockguy2009   (+0.00%)
    BEST Trading Signal Has Been Discovered - www.tradi.. - BEST Trading Signal Has Been Discovered - www.trading4gains.info Please Visit The Webpage http://www.trading4gains.info
    +   0 replies


    More Resources

    Graphic_arrow1 About PerkinElmer Inc. - Answers.com

    Graphic_arrow1 Historical Prices - Yahoo

    Graphic_arrow1 Message Boards - BoardCentral.com

    Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




    		IN THE PRESS
    Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch